ALFA Filings
Every announcement, straight from the exchange
Every Windlas Biotech results update announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech reported record FY26 revenue of ₹904 Crore, representing 19% year-on-year growth. Adjusted PAT rose 31% to ₹83 Crore, reflecting strong operational performance.